TSHA
Taysha Gene Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.94
+8.84%Oct 5, 2026, 18:45 UTC
The Phoenix Art Museum received a $5m gift from philanthropist Sukumar Nagendran to expand its Art of Asia galleries from about 6,000 sq. ft to 10,000 sq. ft and create a new 2,000-sq.-ft Nagendran Gallery for the Art of Sri Lanka and South Asia.
Aug 12, 2026, 01:37 UTC
Taysha Gene Therapies, Inc. held its Q2 2026 earnings call on August 11, 2026.
Source:Aug 12, 2026, 01:04 UTC
Taysha Gene Therapies completed dosing in its REVEAL pivotal trial and ASPIRE trial for TSHA-102, its gene therapy candidate for Rett syndrome, and is preparing for a potential biologics license application submission.
Source:Jun 25, 2026, 00:00 UTC
Taysha Gene Therapies signed an underwriting agreement for an underwritten public offering of 32,500,001 common shares and 833,333 pre-funded warrants, with estimated net proceeds of approximately $187.4 million.
Source:Jun 5, 2026, 12:01 UTC
Taysha Gene Therapies granted restricted stock units and stock options to four new employees as an inducement for their employment.
Source: